SCHEMBL438739

SCHEMBL438739

O=C1CC(=O)NC(=O)[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9940861 0.74
SCHEMBL1509853 0.67
SCHEMBL10952924 0.67
Hydrochloric Acid SCHEMBL10924919 0.64
Barbituric Acid SCHEMBL45717 0.63
SCHEMBL1319284 0.63
Thiobarbituric SCHEMBL22275895 0.63
Barbituric Acid SCHEMBL1973450 0.62
Barbituric Acid SCHEMBL1973827 0.62
Barbituric Acid SCHEMBL20522064 0.62 SRC (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291293-B2 Chromophore comprising pyrimidin-2,4,6-trione and/or pyrrolidinedione/2,5-/ derivative with diaminomelamine or aminopurinone groups; quality, thickness; electrooptic films; acentric microstructure NORTHWESTERN UNIVERSITY (US) 2007-11-06 US claimed
US-20050127337-A1 Vapor deposited electro-optic films self-assembled through hydrogen bonding NORTHWESTERN UNIVERSITY 2005-06-16 US claimed
WO-2004079434-A2 VAPOR DEPOSITED ELECTRO-OPTIC FILMS SELF-ASSEMBLED THROUGH HYDROGEN BONDING NORTHWESTERN UNIVERSITY (US) 2004-09-16 WO claimed
US-20230143643-A1 LOW DK COPPER CLAD LAMINATE COMPOSITIONS DESIGNER MOLECULES INC (US) 2023-05-11 US disclosed
US-20230095931-A1 UV-CURABLE RESIN COMPOSITIONS SUITABLE FOR REDISTRIBUTION LAYERS DESIGNER MOLECULES INC (US) 2023-03-30 US disclosed
EP-4097756-A2 UV-CURABLE RESIN COMPOSITIONS SUITABLE FOR REDISTRIBUTION LAYERS Designer Molecules, Inc. (US) 2022-12-07 EP disclosed
US-20220213267-A1 EXTREME HIGH TEMPERATURE STABLE ADHESIVES AND COATINGS DESIGNER MOLECULES, INC 2022-07-07 US disclosed
US-20220204766-A1 HIGH MOLECULAR WEIGHT FLEXIBLE CURABLE POLYIMIDES DESIGNER MOLECULES, INC 2022-06-30 US disclosed
US-20220204696-A1 PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF DESIGNER MOLECULES, INC 2022-06-30 US disclosed
US-20210301133-A1 CURABLE POLYIMIDES DESIGNER MOLECULES INC (US) 2021-09-30 US disclosed
WO-2021154898-A2 UV-CURABLE RESIN COMPOSITIONS SUITABLE FOR REDISTRIBUTION LAYERS DESIGNER MOLECULES, INC (US) 2021-08-05 WO disclosed
US-20050222146-A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2005-10-06 US disclosed
WO-2005058884-A2 CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-06-30 WO disclosed
WO-2005058808-A1 N-SUBSTITUTED-N-SULFONYLAMINOCYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-06-30 WO disclosed
WO-2005049582-A1 METHOD OF PREPARATION OF NOVEL NUCLEOSIDE ANALOGS AND USES AUSPEX PHARMACEUTICALS, INC. (US) 2005-06-02 WO disclosed
WO-2005044201-A2 PH SENSITIVE PRODRUGS OF 2,6-DIISOPROPYLPHENOL AUSPEX PHARMACEUTICALS, INC. (US) 2005-05-19 WO disclosed
US-6815183-B1 Plasmodium sp. chitinase THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2004-11-09 US disclosed
WO-2004064745-A2 METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES AUSPEX PHARMACEUTICALS, INC. (US) 2004-08-05 WO disclosed
WO-2000073488-A9 PLASMODIUM SP. CHITINASE UNIV TEXAS (US) 2002-04-18 WO disclosed
WO-2000073488-A1 PLASMODIUM SP. CHITINASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-12-07 WO disclosed